O'Sullivan M J, Kaleem Z, Bolger M J, Swanson P E, Zutter M M
Lauren V. Ackerman Laboratory of Surgical Pathology, Washington University Medical Center, St. Louis, MO 63110, USA.
Arch Pathol Lab Med. 2000 Jun;124(6):907-9. doi: 10.5858/2000-124-0907-CPAHTO.
The indolent course of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is occasionally altered by transformation to a histologically distinct, rapidly progressive, and clinically unresponsive hematologic malignant neoplasm. We report a case of CLL that, after 3 years of slowly progressive disease and treatment with single-agent chemotherapy (fludarabine phosphate), underwent a composite prolymphocytoid and classic Hodgkin lymphoma transformation. The diagnosis of classic Hodgkin lymphoma was based on the presence of Reed-Sternberg cells with typical morphologic structure and immunophenotype (CD15(+), CD30(+), CD45(-), CD20(-)) associated with the characteristic polymorphous inflammatory background consisting of numerous eosinophils, plasma cells, and reactive T lymphocytes. The remainder of the lymph node and the peripheral blood showed increased numbers of prolymphocytes admixed with typical small CLL cells. Recognition of such a transformation is of the utmost importance, since histologically similar Reed-Sternberg-like cells may be seen in Richter transformation. In contrast to prolymphocytoid transformation of CLL, Richter syndrome is rapidly fatal, with a median survival of 4 to 5 months. The patient pursued a clinical course similar to pure prolymphocytoid transformation and died with disease after 30 months following treatment with combination chemotherapy.
慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(CLL/SLL)的惰性病程偶尔会因转变为组织学上不同、进展迅速且临床无反应的血液系统恶性肿瘤而改变。我们报告一例CLL患者,在经历3年缓慢进展性疾病并接受单药化疗(磷酸氟达拉滨)治疗后,发生了复合性幼淋巴细胞样和经典霍奇金淋巴瘤转化。经典霍奇金淋巴瘤的诊断基于存在具有典型形态结构和免疫表型(CD15(+)、CD30(+)、CD45(-)、CD20(-))的里德-斯腾伯格细胞,以及由大量嗜酸性粒细胞、浆细胞和反应性T淋巴细胞组成的特征性多形性炎症背景。淋巴结其余部分和外周血显示幼淋巴细胞数量增加,并混有典型的小CLL细胞。认识到这种转化至关重要,因为在 Richter 转化中可能会看到组织学上类似里德-斯腾伯格样的细胞。与CLL的幼淋巴细胞样转化不同,Richter 综合征进展迅速,中位生存期为4至5个月。该患者的临床病程与单纯幼淋巴细胞样转化相似,在接受联合化疗30个月后死于疾病。